glp-1 gastroparesis Risk: What Patients Need to Know GLP-1 Drugs and Gastroparesis: What

Med 2012, 745483

Horticulturae 8:184

I talked to Dr

As we age, metabolism changes, hunger hormones shift, stress mounts and lifestyle factors add fuel to the fire

In the most recent American Association of Clinical Endocrinology clinical practice guidelines for the diagnosis and management of NAFLD it was recommended to administer pioglitazone (PIO) or glucagon-like peptide 1 receptor (GLP-1R) agonists with proven benefit for patients with T2D and biopsy-proven NASH, while these medications should be considered when there is high probability of having NASH (based on higher plasma aminotransferase levels and non-invasive tests) [40]